Monument Therapeutics started as a research project within Cambridge Cognition to develop a better way to stratify patients based on measurable brain function rather than broad diagnoses and, therefore, create more homogeneous patient groups that would respond predictably to specific treatments.
Monument Therapeutics has raised €1.0M across 1 funding round from 4 investors, most recently a round in Feb 2025. Based in Cambridge, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-25 | Other |
| €1.0M |
| ACF investors,Angel Investors,o2h Ventures,Wren Capital |
| View deal → |
